How many studies have been conducted on Dextran Sulfate?

BiohacksAI has indexed 300 PubMed studies on Dextran Sulfate, including 1 randomized controlled trials (RCTs). 9% of studies involve human subjects.

What are the main research areas for Dextran Sulfate?

The primary research domains for Dextran Sulfate are ❤️ Cardiovascular, 🧠 Focus & Attention, 🦠 Gut & Microbiome. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Dextran Sulfate

an anticoagulant and also has been shown to inhibit the binding of HIV-1 to CD4-POSITIVE T-LYMPHOCYTES. It is commonly used as both an experimental and clinical laboratory reagent and has been investigated for use as an antiviral agent, in the treatment of hypolipidemia, and for the prevention of free radical damage, among other applications.

300+ PubMed studies analyzed · 1 RCTs · Evidence Score: 40.2

Research Domains

Dextran Sulfate has been studied across 17 research domains including ❤️ Cardiovascular, 🧠 Focus & Attention, 🦠 Gut & Microbiome, 🔬 Oncology, 🔬 Inflammation. The primary research focus is ❤️ Cardiovascular with 12% of studies addressing this area.

Loading evidence profile...

This evidence profile for Dextran Sulfate is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.